Safety and Efficacy of Fibryga in Congenital Fibrinogen Deficiency

FIB Grifols Congenital Deficiency for On-demand Treatment and Surgical Prophylaxis

NCT04636268 ·Status: WITHDRAWN ·Phase: PHASE3

Study to Assess the Efficacy, Safety and Pharmacokinetic of Octafibrin in Paediatric Subjects With Fibrinogen Deficiency

NCT02408484 ·Status: COMPLETED ·Phase: PHASE3

Study to Investigate the Long-term Efficacy and Safety of Human-cl rhFVIII in Previously Treated Patients (PTPs)

NCT01341912 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Congenital Factor VII Deficiency

NCT01779921 ·Status: COMPLETED

Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of a Recombinant FVIII in Patients With Severe Hemophilia A

NCT00989196 ·Status: COMPLETED ·Phase: PHASE2

Post-Marketing Safety Study Following Long-Term Prophylactic OptivateTreatment in Subjects With Severe Haemophilia A

NCT01811875 ·Status: TERMINATED ·Phase: PHASE4

Kogenate FS Regulatory Post-Marketing Surveillance

NCT01386268 ·Status: COMPLETED

Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany

NCT00697320 ·Status: COMPLETED

Metformin Use in Cardiac Fibrosis in PAI-1 Deficiency

NCT05317806 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Effectiveness of Different Fibrinogen Preparations in Restoring Clot Firmness

NCT05780125 ·Status: COMPLETED ·Phase: PHASE2

Thrombin Generation Assay (TGA) as Predictive Test for Haemostatic. Effectiveness of FVIII Concentrates in Haemophiliac A With Inhibitors

NCT01505946 ·Status: UNKNOWN

Study of the Pharmacokinetics and Safety of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) in Patients With Congenital Factor VII Deficiency

NCT02470871 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics, Efficacy, and Safety of Human Plasma-Derived Fibrinogen (FIB Grifols) in Participants With Congenital Afibrinogenemia

NCT02281500 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Trial to Evaluate the Efficacy and Safety of a New Full Length Recombinant Human FVIII for Hemophilia A

NCT01029340 ·Status: COMPLETED ·Phase: PHASE3

Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 Trial

NCT02541942 ·Status: COMPLETED ·Phase: PHASE2

Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical Procedures

NCT01913405 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating ReFacto® in Hemophilia A Undergoing Major Surgery

NCT00092976 ·Status: COMPLETED ·Phase: PHASE4

Human Cell Line-derived Recombinant Factor VIII (Human-cl-rhFVIII) in Previously Untreated Patients

NCT01712438 ·Status: COMPLETED ·Phase: PHASE3

FEIBA to Optimize Postcardiopulmonary Bypass Hemostasis in Pediatric Cardiac Patients

NCT05020483 ·Status: WITHDRAWN ·Phase: PHASE2

Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients

NCT03695978 ·Status: RECRUITING

Non-interventional Observation of Practical Implementation, Efficacy and Safety of Continuous Infusion With KOGENATE Bayer in Surgery

NCT00922597 ·Status: COMPLETED

EFFEKT - Efficacy and Safety of Long-term Treatment With KOGENATE Bayer/FS

NCT00874926 ·Status: COMPLETED

An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B

NCT06008938 ·Status: RECRUITING

Study of the Efficacy of Human Recombinant Factor VIII (Kogenate FS) Reconstituted in Pegylated Liposomes.

NCT00245297 ·Status: COMPLETED ·Phase: PHASE2

Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX

NCT00710619 ·Status: COMPLETED